• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BTG BOTHELL EKOSONIC KIT 106CM 12CM TZ; CATHETER, CONTINUOUS FLUSH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BTG BOTHELL EKOSONIC KIT 106CM 12CM TZ; CATHETER, CONTINUOUS FLUSH Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Hemorrhage/Bleeding (1888); Hemorrhage, Cerebral (1889); No Code Available (3191)
Event Date 04/01/2020
Event Type  Death  
Manufacturer Narrative
Beyer, s.E., sanafelt, c., pinto, d.S., weinstein, j.L., aronow, h.D., weinberg, i., carroll, b.J.(2020).Utilization and outcomes of thrombolytic.Utilization and outcomes of thrombolytic, chest(157), 645-653.
 
Event Description
Reported via journal article, bleeding requiring transfusion, surgical thrombectomy, and in hospital mortality occurred.The purpose of the article is to examine practice patterns of systemic thrombolysis and catheter-directed thrombolysis (cdt) and to compare outcomes following cdt with ultrasound facilitation (cdt-ultrasound) and cdt alone.Although various forms of catheter-directed thrombolysis (cdt) exist, the best studied and only device approved by the us food and drug administration for the management of pe is the ekosonic endovascular system (ekos).Although there were clear differences between patients receiving systemic thrombolysis and cdt, there were minimal differences in baseline patient characteristics and comorbidities between cdt-ultrasound and cdt alone.In addition, associated high-risk features of acute pe, including mechanical ventilation, hypotension, shock, and vasopressor utilization, were similar.We found no differences in bleeding, in-hospital mortality, or readmissions between cdt-ultrasound and cdt alone.Notably, the rate of major bleeding was similar to that seen in the seattle ii trial.Rates of intracranial hemorrhage were low, and they occurred in 0.6% of patients receiving cdt ultrasound.No further information is known regarding the patient events.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EKOSONIC KIT 106CM 12CM TZ
Type of Device
CATHETER, CONTINUOUS FLUSH
Manufacturer (Section D)
BTG BOTHELL
11911 north creek parkway s.
bothell WA 98011 8809
Manufacturer (Section G)
BTG BOTHELL
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key10079521
MDR Text Key191714232
Report Number2134265-2020-06842
Device Sequence Number1
Product Code KRA
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K182324
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 05/21/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/21/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/30/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
-
-